Hussain F M, Heilbron M
Department of Vascular Surgery, Harbor UCLA Medical Center, Torrance 90502, USA.
J Clin Laser Med Surg. 1997;15(2):57-63. doi: 10.1089/clm.1997.15.57.
Transmyocardial laser revascularization is an investigational procedure that improves chronic angina that is not amenable to other forms of therapy. The theorized mechanism is an increased supply of oxygenated blood to the myocardium via the creation of left ventricular transmural channels. The objective of this review is to facilitate an understanding of the current work published in the literature on the subject of transmyocardial laser revascularization.
Using Melvyl Medline, all pertinent literature associated with transmyocardial laser revascularization was sought and reviewed.
The research in transmyocardial laser revascularization is growing. The results of the current work in animals is conflicting with some showing a benefit from this procedure and others that refute its effectiveness. This may be the outcome of differing methodology, which has yet to be evaluated. Although the results of human trials are positive, the overall effectiveness in comparison with the conventional forms of therapy has not been addressed. It is, therefore, a procedure worthy of continued study.
心肌激光血运重建术是一种用于改善对其他治疗方法无效的慢性心绞痛的研究性手术。其理论机制是通过在左心室壁上创建通道,增加心肌的氧合血液供应。本综述的目的是促进对目前发表在文献中关于心肌激光血运重建术主题的研究的理解。
利用Melvyl医学文献数据库,查找并回顾了所有与心肌激光血运重建术相关的文献。
心肌激光血运重建术的研究正在不断发展。目前动物实验的结果相互矛盾,一些研究表明该手术有益,而另一些则反驳其有效性。这可能是由于不同的方法学导致的,尚未得到评估。尽管人体试验结果是积极的,但与传统治疗方法相比的总体有效性尚未得到探讨。因此,这是一个值得继续研究的手术。